Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. Introduction.
Moellering
R C
RC
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D024841:Fluoroquinolones; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D009287:Naphthyridines / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin